Ngwa nnwale SARS-CoV-2 IgM/IgG(Colloidal Gold)
Nkọwa ngwa:
Nchọpụta nha na ọdịiche nke ọgwụ mgbochi IgM na IgG na SARS-CoV-2 na serum, plasma (EDTA, sodium citrate na lithium heparin) ma ọ bụ mkpịsị aka ọbara dum, ụdị ọbara niile nke venous sitere na ndị ọrịa a na-enyo enyo na ọ bụ ọrịa COVID-19 site n'aka onye na-ahụ maka ahụike.
Nchọpụta nha na ọdịiche nke ọgwụ mgbochi IgM na IgG na SARS-CoV-2 na serum, plasma (EDTA, sodium citrate na lithium heparin) ma ọ bụ mkpịsị aka ọbara dum, ụdị ọbara niile nke venous sitere na ndị ọrịa a na-enyo enyo na ọ bụ ọrịa COVID-19 site n'aka onye na-ahụ maka ahụike.
Nkọwapụta
1T/Kit, 20T/Kit
Atụmatụ & uru
■Ejikwa Nucleocapsid ahọpụtara nke ọma na Spike protein antigen kpuchie ya.
∎ Nchọpụta maka ọgwụ mgbochi IgM na IgG n'otu oge.
■ Ọrụ dị mfe, a kọwapụtara nsonaazụ dị mfe.
Nnwale ngwa ngwa n'ime nkeji iri na ise.
Ihe omume
- Nkwekọrịta Pasent ziri ezi(PPA)=91.07%(153/168)(95% Cl:85.70%-94.92%).
- Agreement Pasent Na-adịghị mma (NPA)=95.37%(103/108)(95% Cl:89.53%-98.48%).
- Ọnụego nkwekọrịta n'ozuzu (ORA)=92.75%((153+103)/(168+108))(95% Cl:89.03%-95.52%).
Nchekwa
1.Ngwa ule na-enwe mmetụta maka iru mmiri yana yana ikpo ọkụ.
2. Chekwaa akụrụngwa akụrụngwa na 2-30℃ma ejikwala mgbe ụbọchị ngwụcha gachara na labelụ mpụta igbe.
